"Sol-Gel Technologies Announces FDA Acceptance for Filing of New Drug Application for Epsolay® for the Treatment of Inflammatory Lesions of R..."
about Sol-Gel Technologies Ltd.
Notified: 16:01 EDT at $7.69
"Intersect ENT Announces Specialty Pharmacy Partnership Agreement with AllianceRx Walgreens Prime to Distribute SINUVA® Sinus Implant"
about Intersect ENT, Inc.
Notified: 17:30 EDT at $18.18
"Algonquin Power & Utilities Corp. Agrees to Acquire Interest in Chilean Water Utility ESSAL"
about Algonquin Power & Utiliti..
Notified: 04:34 EDT at $13.79
"MediciNova Announces that BioComo’s Intranasal RS Virus Vaccine Successfully Induced Neutralizing Antibodies against the RS Virus in Mice us..."
about MediciNova, Inc.
Notified: 06:30 EDT at $5.39
"Zentalis Pharmaceuticals to Host a Key Opinion Leader Virtual Meeting to Discuss its Investigational WEE1 Inhibitor ZN-c3 and its Potential ..."
about Zentalis Pharmaceuticals,..
Notified: 07:00 EDT at $28.90
"Seres Therapeutics Announces U.S. Food and Drug Administration Correspondence Following Positive SER-109 Phase 3 Study Results"
about Seres Therapeutics, Inc.
Notified: 07:01 EDT at $24.24
"Armata Pharmaceuticals Announces Participation in Upcoming Investor Conferences"
about Armata Pharmaceuticals In..
Notified: 07:31 EDT at $3.18
"Atara Biotherapeutics Announces All Progressive Multiple Sclerosis Patients with Sustained Disability Improvement at Six Months Confirmed Im..."
about Atara Biotherapeutics, In..
Notified: 08:01 EDT at $14.24
"CytoSorbents Highlights CytoSorb Use in Sepsis Patients During Sepsis Awareness Month and World Sepsis Day 2020"
about Cytosorbents Corporation
Notified: 08:01 EDT at $7.91
"Veracyte Announces Initiation of Consensus Study Exploring Medical Utility of Multiple Breast Cancer Genomic Tests"
about Veracyte, Inc.
Notified: 08:16 EDT at $30.24
"Clearside Biomedical’s Oncology Licensing Partner Doses First Patient in its Phase 2 Study in Patients with Choroidal Melanoma Using SCS Mic..."
about Clearside Biomedical, Inc..
Notified: 08:30 EDT at $1.66
"AIkido Pharma Announces Peer-Reviewed Publication of Positive Results from Study of Antiviral Compounds Licensed from University of Maryland..."
about AIkido Pharma Inc.
Notified: 09:00 EDT at $0.78
Notice: Price change for each notified stock are being tracked by Preticks after signal notification and given stock price change analysis in this daily summary is being calculated accordingly. You can explore details for each notified signal in daily detailed performance analysis page.